PhaseRx, Inc.
PZRXQ
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 806.00K | 1.07M | 1.59M | 1.24M | 1.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.54M | 3.32M | 3.92M | 3.27M | 3.14M |
| Operating Income | -2.54M | -3.32M | -3.92M | -3.27M | -3.14M |
| Income Before Tax | -2.75M | -3.54M | -4.13M | -3.48M | -3.34M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.75M | -3.54M | -4.13M | -3.48M | -3.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.75M | -3.54M | -4.13M | -3.48M | -3.34M |
| EBIT | -2.54M | -3.32M | -3.92M | -3.27M | -3.14M |
| EBITDA | -2.52M | -3.30M | -3.89M | -3.25M | -3.12M |
| EPS Basic | -0.24 | -0.30 | -0.35 | -0.30 | -0.29 |
| Normalized Basic EPS | -0.15 | -0.19 | -0.22 | -0.19 | -0.18 |
| EPS Diluted | -0.24 | -0.30 | -0.35 | -0.30 | -0.29 |
| Normalized Diluted EPS | -0.15 | -0.19 | -0.22 | -0.19 | -0.18 |
| Average Basic Shares Outstanding | 11.69M | 11.69M | 11.69M | 11.69M | 11.69M |
| Average Diluted Shares Outstanding | 11.69M | 11.69M | 11.69M | 11.69M | 11.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |